tweetindex

Wedbush

@Wedbush · Pasadena, CA · joined 30 Sep 2011

A client-driven financial services firm. Founded in the golden state, with global reach. Member NYSE/FINRA/SIPC

11 776Followers
235Following
7 688Posts total
2.6KViews on collected posts

Against accounts of the same size

5 posts from the last 90 days, next to the 10K–100K follower range. below its peers on both reach and engagement.

Median views509this account3 137median for 10K–100K
Reach, %4.32%this account10.26%median for 10K–100K
Engagement, %0.47%this account1.47%median for 10K–100K
MetricThis accountMedian for 10K–100KRatio
Median views per post5093 1370.16×
Reach (views ÷ followers)4.32%10.26%0.42×
Engagement rate0.47%1.47%0.32×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

5097 Aug
63411 Aug
63218 Aug
42819 Aug
37821 Aug

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.79%7 Aug
1.42%11 Aug
0.47%18 Aug
0.00%19 Aug
0.26%21 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.47%.

What the audience does

Likes70.6%12 in total
Replies29.4%5 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

The biggest changes to family tax benefits in decades took effect in 2026. There are five months left to make sure you're taking full advantage. Here's the checklist. https://t.co/x7yv1TCsOm👨‍👩‍👧‍👦 #Wedbush #TaxCredits #FamilyFinance #FinancialFocus 378 views · 0 likes · 0 reposts · 1 replies 21 Aug 2026 Equity Research Analyst, David Nierengarten, Ph.D. initiated on Aktis Oncology ($AKTS) at #OUTPERFORM ($35 PT). AKTS is developing targeted cancer therapies that deliver a radioactive payload directly to tumor cells, killing them from within while sparing healthy tissue. Two 428 views · 0 likes · 0 reposts · 0 replies 19 Aug 2026 Multiple sclerosis is complicated enough, especially when current treatments each add their own toxicity risks. Equity Research Analyst, Martin Fan, Ph.D. initiated coverage on @ImmunicInc (IMUX) at #OUTPERFORM with a $45 price target. Martin sees a de-risked readout for http 632 views · 2 likes · 0 reposts · 1 replies 18 Aug 2026 Equity Research Analyst, Matt Bryson initiated coverage on @SKhynix (000660.KS) at #OUTPERFORM with a KRW2,560,000 price target. The memory cycle playing out today is unlike anything seen before, with severe undersupply, no inventory builds, and multi-year lead times before new 634 views · 6 likes · 0 reposts · 3 replies 11 Aug 2026 We are proud to share that Wedbush has been named one of the 2026 Best Places to Work by the @LABJnews! This is the result of the culture we've built together over the past 71 years, shaped by the ideas, feedback, and dedication our colleagues bring to work every day. Back in 509 views · 4 likes · 0 reposts · 0 replies 07 Aug 2026

Similar accounts